Back to results
US 8,278,324 B2Granted
Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)
AssigneeGlaxo Group Limited
InventorsJag Paul Heer, Thomas Daniel Heightman
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel oxadiazole derivatives having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
Claims3
A compound of formula (I) or a pharmaceutically acceptable salt thereof:
- wherein
- A is phenyl;
- R1 is up to two substituents independently selected from chloro, isopropoxy, and cyano;
- R2 is hydrogen or methyl;
- B is:
- R3 is hydrogen, methyl or (CH2)1-3CO2H;
- R4 is hydrogen.
4 more elements
A compound selected from:
- 5-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1,2,3,4-tetrahydroisoquinoline;
- 2-[(1-methylethyl)oxy]-5-[3-(1,2,3,4-tetrahydro-5-isoquinolinyl)-1,2,4-oxadiazol-5-yl ]benzonitrile;
- [5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-3,4-dihydro-2(1H)-isoquinolinyl]acetic acid;
- 3-[5-(5-{3-cyano-4-[(1-methylethy)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-3,4-dihydro-2(1H)-isoquinolinyl]propanoic acid;
- 4[-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-3,4-dihydro-2(1H)-isoquinolinyl]butanoic acid;
- 2-[(1-methylethl)oxy]-5-[3-(2-methyl-1,2,3,4-tetrahydro-5-isoquinolinyl)-1,2,4-oxadiazol-5-yl]benzonitrile;
- [8-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-chromen-4-yl]acetic acid;
- 3-[6-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-methyl-3,4dihydro-2(1H)-isoquinolinyl]propanoic acid;
- [6-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinyl]acetic acid;
- 6-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-methyl-1,2,3,4tetrahydroisoquinoline;
- 2-[(1-Methylethyl)oxy]-5-[3-(5-methyl-1,2,3,4-tetrahydro-6-isoquinolinyl)-1,2,4-oxadiazol-5-yl]benzonitrile;
- [6-(5-{3-Cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinyl]acetic acid;
- 3[6-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-methyl-3,4dihydro-2(1H)-isoquinolinyl]propanoic acid;
- or a pharmaceutically acceptable salts thereof.
11 more elements
Dependencies are inferred from the claim text.